Patent details

EP2300431 Title: Process for the manufacture of an intermediate in the synthesis of dabigatran

Basic Information

Publication number:
EP2300431
PCT Application Number:
PCT/EP/2009/057265
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097657944
PCT Publication Number:
WO/2009/153214
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Process for the manufacture of an intermediate in the synthesis of dabigatran
French Title of Invention:
Procédé de fabrication d'un produit intermédiaire dans la synthèse de dabigatran
German Title of Invention:
Verfahren zur Herstellung eines Zwischenprodukts bei der Synthese von Dabigatran
SPC Number:

Dates

Filing date:
12/06/2009
Grant date:
06/01/2016
EP Publication Date:
06/01/2016
PCT Publication Date:
23/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/03/2011
EP B1 Publication Date:
06/01/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/06/2016
Expiration date:
12/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/06/2009
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:
HEDDESHEIMER Ingo
Address:
Germany (DE)

2

Name:
SCHOLZ Ulrich
Address:
Germany (DE)

Priority

Priority Number:
08158363
Priority Date:
16/06/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 213/75;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages